KIN
NASDAQ:KIN
Kindred Biosciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.kindredbio.comipo date
Dec 12, 2013
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus